Injective ETF Gets Nasdaq Approval in Major Institutional Breakthrough
Injective (
@injective) says Nasdaq has approved the listing of its first staked INJ ETF.
The fund will trade under the ticker INJC and target staking 90% of its institutional holdings in the US.
The approval could give traditional investors a regulated route to gain exposure to $INJ.